Insider Trading History of Gupta Renu

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Gupta Renu since 2011. The trader's CIK number is 1269592. At the time of the last reporting, Gupta Renu was the EVP & Chief Medical Officer of Corbus Pharmaceuticals Holdings, Inc.. (stock ticker symbol CRBP). Also see all insider trading activities at Corbus Pharmaceuticals Holdings, Inc..

Note that in the past GUPTA RENU also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Insmed Inc (INSM) by Gupta Renu

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 INSM 0 $0 0 $0 27,900 $0
2013 INSM 0 $0 0 $0 27,900 $0
2011 INSM 2,000 $12,650 0 $0 0 $0

Yearly summary of insider trading at Corbus Pharmaceuticals Holdings, Inc. (CRBP) by Gupta Renu

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 CRBP 10,000 $18,945 0 $0 0 $0
2014 CRBP 5,000 $15,000 0 $0 0 $0


Insider trading activities at 2 companies by Gupta Renu:

1. Insmed Inc (INSM)

2. Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Table 1. Insider trading of Insmed Inc (INSM) by Gupta Renu

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-01-31 INSM Option Ex 27,900 .00 0
2013-06-28 INSM Option Ex 27,900 .00 0
2011-03-28 INSM Buy 1,000 6.50 6,500
2011-03-25 INSM Buy 1,000 6.15 6,150

Table 2. Insider trading of Corbus Pharmaceuticals Holdings, Inc. (CRBP) by Gupta Renu

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-08-18 CRBP Buy 5,000 1.90 9,500
2015-08-17 CRBP Buy 5,000 1.89 9,445
2014-12-04 CRBP Buy 5,000 3.00 15,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gupta Renu (EVP & Chief Medical Officer of Corbus Pharmaceuticals Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.